glp-1 drug news today New research is challenging long-held assumptions about drugs in weight loss treatments. A different approach may be emerging. Click the link in bio to read the full story GLP-1 Agonists Weight Loss Drugs
Description
A study shows that GLP-1 receptor agonists show a notably reduced incidence of primary open-angle glaucoma (POAG), ocular hypertension, and the requirement for first-line glaucoma treatments compared to metformin in individuals with type 2 diabetes (80)
Without insurance coverage, GLP-1 medications can cost $936 to $1,349 per month, so the Bridge Program represents a significant reduction in out-of-pocket costs
Ahmed GU et al
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial
Nicholas J
The I148 M allele of PNPLA3, is associated with MASLD in both children and adults [12]
